🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12496+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12496 recruiting trials

Phase 1, PHASE2RecruitingNCT05918640

Lurbinectedin in FET-Fused Tumors

👨‍⚕️ Theodore Laetsch, MD, Children's Hospital of Philadelphia📍 6 sites📅 Started Jul 2023View details ↗
RecruitingNCT05978141

A Registry for People With T-cell Lymphoma

👨‍⚕️ Steven Horwitz, MD, Memorial Sloan Kettering Cancer Center📍 26 sites📅 Started Jul 2023View details ↗
NARecruitingNCT07246122

MRI-Guided Dynamic Support System for Scoliosis Correction

👨‍⚕️ Raymond Tong, PhD, Chinese University of Hong Kong📍 1 site📅 Started Jul 2023View details ↗
NARecruitingNCT05828810

CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee

👨‍⚕️ Raman Mundi, MD MSc FRCSC, Sunnybrook Health Sciences Centre📍 3 sites📅 Started Jul 2023View details ↗
RecruitingNCT07392411

Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers

🏥 Beijing Tiantan Hospital📍 1 site📅 Started Jul 2023View details ↗
Phase 3RecruitingNCT06243640

Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD

🏥 Beijing Union Pharmaceutical Factory Ltd📍 1 site📅 Started Jul 2023View details ↗
Phase 1, PHASE2RecruitingNCT05955105

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

👨‍⚕️ Jin Li, M.D., Shanghai East Hospital📍 1 site📅 Started Jul 2023View details ↗
Phase 3RecruitingNCT05849779

Inhaled Sevoflurane for ARDS Prevention

👨‍⚕️ Matthieu JABAUDON, University Hospital, Clermont-Ferrand📍 1 site📅 Started Jul 2023View details ↗
Phase 2RecruitingNCT05835466

Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

👨‍⚕️ Marina Kremyanskaya, PhD, MD, Icahn School of Medicine at Mount Sinai📍 9 sites📅 Started Jul 2023View details ↗
NARecruitingNCT05926011

Efficacy of RGn600 in Patients With Mild-to-moderate Alzheimer's Disease

👨‍⚕️ Guillaume BLIVET, REGEnLIFE SAS📍 6 sites📅 Started Jul 2023View details ↗
Phase 1, PHASE2RecruitingNCT05473156

A Study to Investigate the Safety, Pharmacokinetics, and Clinical Activity of AP203 in Patients with Locally Advanced or Metastatic Solid Tumors, and Expansion to Selected Malignancies

🏥 AP Biosciences Inc.📍 1 site📅 Started Jul 2023View details ↗
Enrolling by InvitationNCT06103487

Long Term Follow-Up for RGX-111

🏥 REGENXBIO Inc.📍 2 sites📅 Started Jul 2023View details ↗
EARLY_Phase 1RecruitingNCT05838599

Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides

👨‍⚕️ Alan Zhou, Northwestern University📍 1 site📅 Started Jul 2023View details ↗
NARecruitingNCT05664646

Autonomic Effects of Stimulation in SCI

👨‍⚕️ Jill Wecht, EdD, James J. Peters Veterans Affairs Medical Center📍 1 site📅 Started Jul 2023View details ↗
Phase 1RecruitingNCT05879367

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

👨‍⚕️ Howard Colman, MD, PhD, Huntsman Cancer Institute/ University of Utah📍 8 sites📅 Started Jul 2023View details ↗
Phase 3RecruitingNCT07062263

Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients

👨‍⚕️ Vikas Ostwal, DM, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India 400012📍 6 sites📅 Started Jul 2023View details ↗
RecruitingNCT06387719

Precursors of Binge Eating Disorder in a Clinical Sample of Adolescents With Obesity

👨‍⚕️ Esther Via, PhD, Hospital Sant Joan de Deu📍 1 site📅 Started Jul 2023View details ↗
RecruitingNCT05859191

Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus

👨‍⚕️ Yanis RAMDANI, CHRU de Tours📍 1 site📅 Started Jul 2023View details ↗
RecruitingNCT06031636

Oncolytic Adenovirus(H101) Combined With PD-1 Inhibitors in Patients With Advanced Malignant Pleural Mesothelioma

🏥 Tianjin Medical University Second Hospital📍 1 site📅 Started Jul 2023View details ↗
RecruitingNCT05939232

Registry of X-linked Adrenoleukodystrophy

👨‍⚕️ Yilong Wang, MD,PhD, Beijing Tiantan Hospital, Capital Medical University, Beijing, China📍 1 site📅 Started Jul 2023View details ↗
← PreviousPage 389 of 625Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →